People: Molecular Biologist Returns To U.S. After 22-Year Stint In France

Date: December 7, 1992 After 22 years in the French molecular biology community, Edward N. Brody is returning to the United States. Though originally from Chicago, Brody has spent four years as research director in the Centre de Genetique Moleculaire at the French National Research Council and 18 years as a research director at the Institut de Biologie Physico-chimique. He has now taken a position as chairman of the department of biological sciences at the State University of New York at Buff

Written byRon Kaufman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Date: December 7, 1992

After 22 years in the French molecular biology community, Edward N. Brody is returning to the United States. Though originally from Chicago, Brody has spent four years as research director in the Centre de Genetique Moleculaire at the French National Research Council and 18 years as a research director at the Institut de Biologie Physico-chimique. He has now taken a position as chairman of the department of biological sciences at the State University of New York at Buffalo, and is also a professor in the department. He began in the job in October.

In his new position, Brody will continue his laboratory studies in pre-messenger RNA splicing in vertebrates. He says understanding how RNA splicing is regulated is important to investigations into the development of retroviruses, such as HIV.

In 1985, while on a two-year sabbatical at the California Institute of Technology, Brody published an article ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies